McIlrath & Eck’s Cardinal Health CAH Stock Holding History

McIlrath & Eck’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-261	Closed	-$13K	–	801
2021 Q3	$13K	Buy	+261	New	+$14.2K	﹤0.01%	478

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McIlrath & Eck's CAH Position: Q4 2021 in Review

McIlrath & Eck sold out of Cardinal Health (CAH) in Q4 2021, closing a stake of 261 shares — an estimated $13K sold.

McIlrath & Eck first reported a position in CAH in Q3 2021 and held it in 1 quarter. The position peaked at $13K in Q3 2021. 779 funds tracked by Wall St. Rank hold CAH as of Q4 2021.

McIlrath & Eck reported no remaining Cardinal Health position as of Q4 2021 after selling out during the quarter.
McIlrath & Eck sold 261 Cardinal Health shares in Q4 2021, an estimated $13K.
McIlrath & Eck first reported a position in Cardinal Health in Q3 2021 and held it in 1 quarter.
McIlrath & Eck's Cardinal Health position peaked at $13K in Q3 2021.
779 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2021.

Based on McIlrath & Eck's 13F filing for Q4 2021, filed 8 Feb 2022.